The Oral Serine Protease Inhibitor WX-671 - First Experience in Patients with Advanced Head and Neck Carcinoma.
Meyer
Jens E
JE
Department of Otorhinolaryngology and Facial Plastic Surgery, University Hospital Schleswig Holstein - Campus Lübeck, Germany.
Brocks
Carsten
C
Graefe
Hendrik
H
Mala
Carola
C
Thäns
Natalie
N
Bürgle
Markus
M
Rempel
Annette
A
Rotter
Nicole
N
Wollenberg
Barbara
B
Lang
Stephan
S
Eur J Cancer. 1998 Jul;34(8):1193-7
9849478
Lancet. 1989 Oct 28;2(8670):1049
2572788
Expert Opin Biol Ther. 2001 Jul;1(4):683-91
11727504
Cancer. 1996 Aug 1;78(3):487-92
8697395
Cell Mol Life Sci. 2000 Jan 20;57(1):25-40
10949579
Head Neck. 2000 Aug;22(5):498-504
10897110
Anticancer Res. 2000 Sep-Oct;20(5C):3975-81
11268487
Int J Oncol. 1998 Nov;13(5):893-906
9772277
Nat Med. 1996 Mar;2(3):287-92
8612226
Cancer. 1988 Aug 1;62(3):531-3
3134120
J Natl Cancer Inst. 2001 Jun 20;93(12):913-20
11416112
Int J Cancer. 2004 Jul 20;110(6):815-24
15170662
Laryngorhinootologie. 2002 Jul;81(7):499-508
12173061
Lancet. 1994 Jan 8;343(8889):117
7903748
Oral Oncol. 1998 Jan;34(1):58-62
9659521
N Engl J Med. 1993 Jan 21;328(3):184-94
8417385
Oral Oncol. 2005 Nov;41(10):971-7
16129656
Cancer Res. 1998 Nov 15;58(22):5221-30
9823336
Thromb Haemost. 1995 Jul;74(1):429-36
8578500
Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5899-904
8650190